Skip to content

The Role of Occupational Therapy for Improving Medication Management for Persons With AMD, DR and Glaucoma

The Role of Occupational Therapy for Improving Medication Management for Persons With AMD, Diabetic Retinopathy (DR) and Glaucoma

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06593405
Enrollment
50
Registered
2024-09-19
Start date
2025-04-22
Completion date
2026-12-05
Last updated
2026-05-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Age-Related Macular Degeneration

Brief summary

The goal of this clinical trial is to learn if education about additional task lighting, enhanced contrast, enlarged print instructions, smart apps and organizational strategies will improve medication management skills. The main questions it aims to answer are: Does additional task lighting, enhanced contrast, enlarged print instructions, smart apps and organizational strategies improve medication management skills, reduce errors and improve functional use of remaining vision for this task? Participants will: Oftentimes, the client is unaware of these strategies which may improve occupational performance during a valued activity. Clients with AMD, DR or Glaucoma who choose to receive the one hour OT service will be provided with 1:1 education regarding the devices and strategies that may improve their ability to perform medication management skills.

Detailed description

Many clients with low vision are unaware of OT, or the services OT can provide to assist with low vision needs. Clients with AMD, DR or Glaucoma who choose to receive the one hour OT service will be provided with 1:1 education regarding the devices and strategies that may improve their ability to perform medication management skills. Clients will complete the MediCog and the Revised-Self-Report Assessment of Functional Visual Performance (R-SRAFVP) assessment tools with the assistance of the OT. These tools will inform the therapist to areas of client needs and allow for focus on intervention to support these challenges. Follow up in OT 4 weeks post intervention will allow therapist to reassess the effectiveness of interventions provided via a phone or in-person interview as well as provide the assessments again. Second set of data from these assessments will be compared to initial findings obtained.

Interventions

COMBINATION_PRODUCToccupational therapy interventions for low vision care

Occupational therapists utilize many different treatment strategies when caring for the client with low vision. Oftentimes, the client is unaware of these strategies which may improve occupational performance during a valued activity. Interventions include task lighting, organizational strategies, smart apps, contrast, enlarged print, typoscopes and electronic magnification devices.

Sponsors

MCPHS University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

This is a quasi-experimental study to determine outcomes with occupational therapy (OT) medication management interventions/strategies for persons with Age-related Macular Degeneration (AMD)

Eligibility

Sex/Gender
ALL
Age
50 Years to 100 Years
Healthy volunteers
Yes

Inclusion criteria

* Clients with AMD, DR or Glaucoma * Clients who choose to participate will allow their deidentified data to be evaluated for outcomes.

Exclusion criteria

* Clients with other age related eye diseases other than AMD, DR or Glaucoma. * Clients who do not wish to participate in this study.

Design outcomes

Primary

MeasureTime frameDescription
Revised Self Report Assessment of Functional VisualResults from the Revised-Self-Report Assessment of Functional Visual Performance assessment will be determined on day 1 and 4 weeks laterA standardized assessment which provides information on how well adults with vision loss can perform daily tasks. This tool has 33 assessment components and a higher score indicates less functional impairment. A lower score indicates a higher impairment.
MediCog Screening ToolResults from the MediCog will be determined on day 1 and will be obtained 4 weeks laterThe Medi-Cog has a maximum score of 10 points, and a score of 7 or lower may indicate cognitive impairment.

Countries

United States

Contacts

CONTACTMichelle Dowling, OTD
michelle.dowling@mcphs.edu508-373-5851
PRINCIPAL_INVESTIGATORMichelle Dowling, OTD

MCPHS University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 13, 2026